휴대용 초음파 방광 스캐너 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 제품별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Portable Ultrasound Bladder Scanner Market Growth & Trends:

The global portable ultrasound bladder scanner market size is anticipated to reach USD 353.8 million by 2030, registering a CAGR of 3.97% from 2025 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to market growth include increasing occurrences of urological disorders, advancements in technology, rising acceptance of point-of-care diagnostic devices, and heightened awareness and education.

The portable ultrasound bladder scanner is an efficient device owing to its versatility, convenience, and accuracy in diagnosing bladder-related issues. In contrast to traditional methods, which frequently involve invasive procedures or prolonged processes, this compact device offers rapid and non-invasive assessments of bladder volume and residual urine.

Technological advancements such as real-time volume calculations, automated bladder recognition, and integration of AI with these devices is expected to boost market growth. For instance, in January 2024, Clarius obtained FDA approval for its Clarius Bladder AI, a non-invasive tool that measures bladder volume within seconds. This innovative solution is currently available in the U.S., compatible with the Clarius PAL HD3, Clarius PA HD3, and the Clarius C3 HD3 wireless handheld ultrasound scanners .

The increasing incidence of urological conditions like bladder cancer, urinary incontinence and many others is anticipated to drive substantial demand for portable ultrasound bladder scanners. For instance, according to the International Agency for Research on Cancer, in 2022, there were about 614,298 cases of bladder cancer globally which is further expected to rise to 1,950,315 by 2027. With aging populations, lifestyle shifts, and heightened awareness leading to earlier detection, these conditions are becoming more prevalent. Consequently, there's a growing necessity for efficient diagnostic tools capable of accurately assessing bladder health.

Portable Ultrasound Bladder Scanner Market Report Highlights:

• Based on product, the 2D segment dominated the market with the largest share of 60.4% in 2024. Its ease of use makes it well-suited for regular exams and quick evaluations.
• The 3D segment is expected to grow at the fastest CAGR during the forecast period. This can be attributed to various factors, including advancements in technology and growing preferences in clinical practice.
• The hospital segment dominated the market with a share of over 40.5% in 2024 and is expected to grow at the fastest CAGR over the forecast period. Hospitals remain the primary option for patients seeking medical care, particularly for conditions like urinary tract infections (UTIs) and urinary incontinence, which require frequent bladder assessments.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product Type
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product type outlook
  • 2.2.2. End use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Portable Ultrasound Bladder Scanner Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing prevalence of urological disorders
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Growing adoption of point-of-care diagnostic devices
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Significant reliance on the operator's skills and expertise.
• 3.3. Portable Ultrasound Bladder Scanner Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Portable Ultrasound Bladder Scanner Market: Product Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Portable Ultrasound Bladder Scanner Product Type Market Movement Analysis
• 4.3. Global Portable Ultrasound Bladder Scanner Market Size & Trend Analysis, by Product Type, 2018 to 2030 (USD Million)
• 4.4. 2D
  • 4.4.1. 2D market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. 3D
  • 4.5.1. 3D market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Portable Ultrasound Bladder Scanner Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Portable Ultrasound Bladder Scanner End Use Market Movement Analysis
• 5.3. Global Portable Ultrasound Bladder Scanner Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Diagnostic Imaging Centers
  • 5.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Portable Ultrasound Bladder Scanner Market: Regional Estimates & Trend Analysis By Product Type, End Use

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Competitive scenario
    • 6.5.1.3. Regulatory framework/ reimbursement structure
    • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Competitive scenario
    • 6.5.2.3. Regulatory framework/ reimbursement structure
    • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. Mexico
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Competitive scenario
    • 6.5.3.3. Regulatory framework/ reimbursement structure
    • 6.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. Regulatory framework/ reimbursement structure
  • 6.6.2. UK
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Competitive scenario
    • 6.6.2.3. Regulatory framework/ reimbursement structure
    • 6.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Competitive scenario
    • 6.6.3.3. Regulatory framework/ reimbursement structure
    • 6.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Competitive scenario
    • 6.6.4.3. Regulatory framework/ reimbursement structure
    • 6.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Competitive scenario
    • 6.6.5.3. Regulatory framework/ reimbursement structure
    • 6.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Competitive scenario
    • 6.6.6.3. Regulatory framework/ reimbursement structure
    • 6.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.7. Norway
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Competitive scenario
    • 6.6.7.3. Regulatory framework/ reimbursement structure
    • 6.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Competitive scenario
    • 6.6.8.3. Regulatory framework/ reimbursement structure
    • 6.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.9. Denmark
    • 6.6.9.1. Key country dynamics
    • 6.6.9.2. Competitive scenario
    • 6.6.9.3. Regulatory framework/ reimbursement structure
    • 6.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Regulatory framework/ reimbursement structure
  • 6.7.2. Japan
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Competitive scenario
    • 6.7.2.3. Regulatory framework/ reimbursement structure
    • 6.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. China
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Competitive scenario
    • 6.7.3.3. Regulatory framework/ reimbursement structure
    • 6.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. India
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Competitive scenario
    • 6.7.4.3. Regulatory framework/ reimbursement structure
    • 6.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.5. Australia
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Competitive scenario
    • 6.7.5.3. Regulatory framework/ reimbursement structure
    • 6.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.6. South Korea
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Competitive scenario
    • 6.7.6.3. Regulatory framework/ reimbursement structure
    • 6.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.7. Thailand
    • 6.7.7.1. Key country dynamics
    • 6.7.7.2. Competitive scenario
    • 6.7.7.3. Regulatory framework/ reimbursement structure
    • 6.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Regulatory framework/ reimbursement structure
  • 6.8.2. Brazil
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Competitive scenario
    • 6.8.2.3. Regulatory framework/ reimbursement structure
    • 6.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Competitive scenario
    • 6.8.3.3. Regulatory framework/ reimbursement structure
    • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. MEA
  • 6.9.1. Regulatory framework/ reimbursement structure
  • 6.9.2. South Africa
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Competitive scenario
    • 6.9.2.3. Regulatory framework/ reimbursement structure
    • 6.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Competitive scenario
    • 6.9.3.3. Regulatory framework/ reimbursement structure
    • 6.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.4. UAE
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Competitive scenario
    • 6.9.4.3. Regulatory framework/ reimbursement structure
    • 6.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key country dynamics
    • 6.9.5.2. Competitive scenario
    • 6.9.5.3. Regulatory framework/ reimbursement structure
    • 6.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Key company market share analysis, 2024
• 7.4. Company Position Analysis
• 7.5. Company Categorization (Emerging Players, Innovators and Leaders
• 7.6. Company Profiles
  • 7.6.1. GE Healthcare
    • 7.6.1.1. Company overview
    • 7.6.1.2. Financial performance
    • 7.6.1.3. Product benchmarking
    • 7.6.1.4. Strategic initiatives
  • 7.6.2. Philips Healthcare
    • 7.6.2.1. Company overview
    • 7.6.2.2. Financial performance
    • 7.6.2.3. Product benchmarking
    • 7.6.2.4. Strategic initiatives
  • 7.6.3. Siemens Healthineers
    • 7.6.3.1. Company overview
    • 7.6.3.2. Financial performance
    • 7.6.3.3. Product benchmarking
    • 7.6.3.4. Strategic initiatives
  • 7.6.4. Verathon Inc.
    • 7.6.4.1. Company overview
    • 7.6.4.2. Financial performance
    • 7.6.4.3. Product benchmarking
    • 7.6.4.4. Strategic initiatives
  • 7.6.5. Infinium Medical
    • 7.6.5.1. Company overview
    • 7.6.5.2. Financial performance
    • 7.6.5.3. Product benchmarking
    • 7.6.5.4. Strategic initiatives
  • 7.6.6. Laborie
    • 7.6.6.1. Company overview
    • 7.6.6.2. Financial performance
    • 7.6.6.3. Product benchmarking
    • 7.6.6.4. Strategic initiatives
  • 7.6.7. Advin Health Care
    • 7.6.7.1. Company overview
    • 7.6.7.2. Financial performance
    • 7.6.7.3. Product benchmarking
    • 7.6.7.4. Strategic initiatives
  • 7.6.8. Caresono Technology Co.,Ltd.
    • 7.6.8.1. Company overview
    • 7.6.8.2. Financial performance
    • 7.6.8.3. Product benchmarking
    • 7.6.8.4. Strategic initiatives
  • 7.6.9. Becton, Dickinson and Company
    • 7.6.9.1. Company overview
    • 7.6.9.2. Financial performance
    • 7.6.9.3. Product benchmarking
    • 7.6.9.4. Strategic initiatives
  • 7.6.10. EchoSon
    • 7.6.10.1. Company overview
    • 7.6.10.2. Financial performance
    • 7.6.10.3. Product benchmarking
    • 7.6.10.4. Strategic initiatives
  • 7.6.11. Vitacon
    • 7.6.11.1. Company overview
    • 7.6.11.2. Financial performance
    • 7.6.11.3. Product benchmarking
    • 7.6.11.4. Strategic initiatives
  • 7.6.12. Medzer
    • 7.6.12.1. Company overview
    • 7.6.12.2. Financial performance
    • 7.6.12.3. Product benchmarking
    • 7.6.12.4. Strategic initiatives
  • 7.6.13. Clarius
    • 7.6.13.1. Company overview
    • 7.6.13.2. Financial performance
    • 7.6.13.3. Product benchmarking
    • 7.6.13.4. Strategic initiatives

Chapter 8. Analyst Perspective